ICD-10: F18.1

Inhalant abuse, classified under ICD-10 code F18.1, refers to the harmful use of inhalants, which can lead to significant health issues. While there are no specific medications approved for treating inhalant use disorder, several treatment approaches can be effective:

• Psychotherapy: Engaging in various forms of psychotherapy, such as cognitive-behavioral therapy (CBT), can help individuals understand their addiction, develop coping strategies, and address underlying psychological issues that may contribute to substance use.

• Substance Abuse Techniques: Techniques that focus on substance abuse treatment, including motivational interviewing and contingency management, can be beneficial. These methods aim to enhance motivation for change and reinforce positive behaviors.

• Support Groups: Participation in support groups, such as Alcoholics Anonymous (AA) or Narcotics Anonymous (NA), can provide a community of individuals who share similar experiences, offering emotional support and accountability.

• Family Therapy: Involving family members in therapy can help address relational dynamics that may contribute to substance use and foster a supportive environment for recovery.

• Education and Prevention Programs: Educating individuals about the risks associated with inhalant use and providing prevention programs can help reduce the incidence of inhalant abuse.

These approaches emphasize a comprehensive treatment plan tailored to the individual's needs, focusing on both psychological and social aspects of recovery [1].